Product image of Hemlibra Injection (Emicizumab) 30mg /ml Vials supplied by GNH India

Hemlibra Injection

Active Ingredient:
Emicizumab
Form:
Vials
Brand:
Hemlibra
Origin:
Switzerland

Hemlibra Injection (Emicizumab Vials) 30mg /ml

Hemlibra Injection (Emicizumab) is a subcutaneous treatment for hemophilia A, designed to help prevent or reduce bleeding episodes. This 30mg/ml vial formulation supports routine prophylaxis in patients with or without factor VIII inhibitors. Store between 2-8°C to maintain potency.

Strength

30mg /ml

Pack Size

1s

Storage

2-8°

Manufacturer / TM Owner

Roche Pharma Switzerland

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Emicizumab is prescribed to prevent or reduce the frequency of bleeding episodes in adults and children with hemophilia A. It is used for routine prophylaxis in patients with or without factor VIII inhibitors, offering an alternative to standard factor replacement therapies. Hemlibra helps manage bleeding risk in this condition.

Side Effects

  • After administration, Emicizumab works by bridging activated factor IX and factor X, supporting blood clotting processes. Patients may notice a reduction in bleeding episodes over time with consistent use. Individual responses can vary based on underlying condition and treatment adherence.

Precautions & Warnings

  • Keep Hemlibra Injection refrigerated between 2-8°C and protect from light. Do not freeze or shake the vial. Always check the solution for particles or discoloration before use. Dispose of used needles and vials properly to prevent accidental injury or contamination.

Avoid Interactions

  • Hemlibra may interact with other medications that affect blood clotting, including anticoagulants and certain antiplatelet drugs. Avoid combining it with products containing factor VIII without medical guidance. Always inform healthcare providers about all medications being taken to assess potential interactions.

Frequently Asked Questions

Hemlibra Injection is used to prevent or reduce bleeding episodes in adults and children with hemophilia A, including those with factor VIII inhibitors.

Store Hemlibra Injection between 2-8°C (36-46°F) and protect it from light. Do not freeze or shake the vial.

Hemlibra may interact with other hemophilia treatments; consult a healthcare provider before combining therapies to assess safety.

Hemlibra is prescribed for routine prophylaxis in hemophilia A patients with or without factor VIII inhibitors, but suitability depends on individual medical assessment.

Inspect the vial for particles or discoloration before use. Ensure the solution is clear and free of visible changes.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Emicizumab

Hemlibra 30mg

Hemlibra 30mg

30mg/1ml Vials
Hemlibra-60mg IND

Hemlibra-60mg IND

60mg/0.4ml Vials
Hemlibra-30mg

Hemlibra-30mg

30mg/ml Vials
Hemlibra 30 mg

Hemlibra 30 mg

30 MG SOLUTION

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT